Not available
Quote | Oxford BioMedica (OTCMKTS:OXBDF)
Last: | $2.615 |
---|---|
Change Percent: | 0.0% |
Open: | $2.615 |
Close: | $2.615 |
High: | $2.615 |
Low: | $2.615 |
Volume: | 600 |
Last Trade Date Time: | 04/11/2024 03:00:00 am |
News | Oxford BioMedica (OTCMKTS:OXBDF)
EXPRESS INC. DL-01 (02Z0:DU) is expected to report $-8.99 for Q4 2024 Oxford Biomedica (OXBDF) is expected to report for Q4 2023 Yaskawa Electric Corporation ADR (YASKY) is expected to report for Q4 2024 Express (02Z0:MU) is expected to report $-8.99 for Q4 2024 Express Inc. - Ord...
Oxford Biomedica (OXBDF) is expected to report for Q4 2023
Message Board Posts | Oxford BioMedica (OTCMKTS:OXBDF)
Subject | By | Source | When |
---|---|---|---|
John Dawson to retire from Oxford Biomedica | georgejjl | investorshub | 01/17/2022 9:30:24 AM |
AstraZeneca vaccine is 79% effective against symptomatic Covid-19, | georgejjl | investorshub | 03/23/2021 1:30:21 AM |
WHO expert group recommends use of AstraZeneca vaccine | georgejjl | investorshub | 02/11/2021 3:37:12 AM |
AstraZenecas (Oxford BioMedica's) vaccine is poised to become | georgejjl | investorshub | 02/05/2021 6:00:33 PM |
WHP completes viral vector manufacturing centre for Oxford Biomedica | georgejjl | investorshub | 12/31/2020 1:59:28 AM |
News, Short Squeeze, Breakout and More Instantly...
EXPRESS INC. DL-01 (02Z0:DU) is expected to report $-8.99 for Q4 2024 Oxford Biomedica (OXBDF) is expected to report for Q4 2023 Yaskawa Electric Corporation ADR (YASKY) is expected to report for Q4 2024 Express (02Z0:MU) is expected to report $-8.99 for Q4 2024 Express Inc. - Ord...
Oxford Biomedica (OXBDF) is expected to report for Q4 2023
LONDON, UK / ACCESSWIRE / October 5, 2020 / Oxford Biomedica (OXB) is a pioneer and global leader in the development and manufacture of commercial-scale lentiviral vectors (LVVs), a critical component of cell and gene therapies (CGTs). An investment in OXB gives a broad exposure to this emer...